Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.
Gemma E CurrieBernt Johan von ScholtenSheon MaryJose-Luis Flores GuerreroMorten LindhardtHenrik ReinhardPeter K JacobsenWilliam MullenHans-Henrik ParvingHarald MischakPeter RossingChristian DellesPublished in: Cardiovascular diabetology (2018)
A multidimensional biomarker can provide information on outcomes associated with its primary diagnostic purpose. Here we demonstrate that the urinary proteomic classifier CKD273 is associated with mortality in individuals with type 2 diabetes and MA even when adjusted for other established cardiovascular and renal biomarkers.